AzTrials
AzTrials

Shoulder Arthroscopic SurgeriesNCT07874672

SPSIP Block in Shoulder Artroscopy

An observational study of Shoulder Arthroscopic Surgeries, run by ULSS6 - Ospedale di Piove di Sacco at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The SPSIP block study aims to systematically describe the distribution of sensory blockade across the region involved in shoulder arthroscopy, as well as the degree of motor sparing of the ipsilateral upper limb and hemidiaphragm. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shoulder Arthroscopic Surgeries
What is being tested?
SPSIPB block
Type of treatment
Surgery or procedure
How many people
20 participants
Where
1 siteItaly
Study dates
14 Oct 2026to Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients undergoing shoulder arthroscopy in the operating rooms of Piove di Sacco Hospital (Italy).

Who may be able to join

  • Patients scheduled for shoulder arthroscopy receiving an SPSIP block as the analgesic technique.
  • Age ≥ 18 years.
  • Patients able to provide informed consent to study participation and to the processing of personal data.

Who cannot join

  • Refusal to provide consent to study participation.
  • Pre-existing central or peripheral sensory neuropathy.
  • Estimated time between block performance and entry into the operating room of less than 30 minutes.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site, 1 recruiting
  • Ospedale di Piove di Sacco

    Piove di Sacco, Padova, 35028

    Alessio Rotondi, MD, +39 3899224280, alessio.rotondi@aulss6.veneto.it

    Recruiting

Other trials in Italy

About this study

Official title: Clinical Effectiveness of the Serratus Posterior Superior Intercostal Plane Block (SPSIP Block) in Shoulder Arthroscopy: an Exploratory Prospective Observational Study

The SPSIP block study aims to systematically describe the distribution of sensory blockade across the region involved in shoulder arthroscopy, as well as the degree of motor sparing of the ipsilateral upper limb and hemidiaphragm. We will assess the sensory response with a cold cotton swab that will be used to compare the sensation of the operated shoulder with that of the opposite (contralateral) shoulder. The patient will be asked whether the feeling of cold is unchanged or altered along the shoulder. This will be tested over an area extending 15 cm anteriorly, laterally and posteriorly. This test will take place 30 min after the SPSIP block. We will also assess the range of motion of the limb undergoing surgery before and after 30 min the anaesthetic procedure. The patient will be asked to perform shoulder abduction and external rotation movements, which the anesthesiologist will explain. We will also measure the diaphragmatic excursion using ultrasound. This procedure will also be performed before and 30 min after the nerve block: the patient will be asked to take deep breaths while the anesthesiologist performs the ultrasound scan.

The study will include adult patients (≥ 18 years) scheduled for shoulder arthroscopy who receive an SPSIP block as the analgesic technique and are able to provide informed consent to study participation and to the processing of personal data will be enrolled.This is a single-centre study conducted exclusively at Piove di Sacco Hospital (Italy).

Read the detailed description

Background The interscalene block, the analgesic gold standard for shoulder arthroscopy, causes hemidiaphragmatic paresis in nearly all patients and significant upper-limb motor block. The serratus posterior superior intercostal plane (SPSIP) block targets the upper thoracic spinal nerves (T2-T5) deep to the serratus posterior superior muscle, far from the brachial plexus and phrenic nerve, and may therefore provide analgesia with less motor and diaphragmatic involvement. Its sensory distribution and diaphragmatic effects have not yet been systematically described.

Design Prospective, single-center, exploratory observational study at Piove di Sacco Hospital (ULSS6 Euganea, Italy). Only patients in whom the attending anesthesiologist has already chosen the SPSIP block are enrolled; all assessments are part of routine care and the study does not modify anesthetic management.

Procedures At the time of the block, age, sex, weight, height, and type, volume and dose of local anesthetic are recorded.

  • Sensory block (30 min after the block): a swab cooled with ice spray is applied from the acromion in 1-cm steps along lateral, anterior and posterior lines (15 cm each). Each point is scored 1 (absent or reduced cold sensation vs. the contralateral side) or 0 (preserved), producing a sensory map.
  • Upper-limb motor function (before and 30 min after the block): shoulder abduction (axillary nerve) and external rotation (suprascapular nerve), elbow at 90°, measured in degrees with a goniometer.
  • Diaphragmatic function (before and 30 min after the block): M-mode ultrasound excursion during deep inspiration. Reduction from baseline is graded 0 (< 25%), 1 (25-75%, partial paresis) or 2 (> 75% or paradoxical movement, complete paralysis).

Surgery is then performed under general anesthesia; no intraoperative or postoperative data are collected.

Statistical analysis A pragmatic sample of 20 patients was chosen, as no formal sample size calculation was possible. Data will be analyzed descriptively; pre- and post-block diaphragmatic excursion will be compared with the paired t-test or Wilcoxon signed-rank test. Results will inform a future confirmatory study.

Being tested
SPSIPB block
Keywords
SPSIP block, shoulder arthroscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPSIPB blockProcedure or surgery

    Also called serratus posterior superior intercostal plane block

    It will be performed the serratus posterior superior intercostal plane block (SPSIP block) before shoulder arthroscopy surgery.

Study groups in NCT07874672
Study groupRoleWhat they receive
Peolple undergoing shoulder arthroscopy surgeriesNot described
Receives: Procedure: SPSIPB block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sensory blockade at 30 minutes

    A cold cotton ball will be applied in the sensory territory of the shoulder in order to describe the loss of sensation by the SPSIP block across in this region

    Measured: 30 min after SPSIP block

Secondary outcomes (3)
  1. Motor sparing (shoulder abduction)

    Motor sparing will also be quantified by assessing shoulder abduction (axillary nerve). The movement will be assessed in degrees using a goniometer

    Measured: 30 minutes post-SPSIP block

  2. Motor sparing (external rotation)

    Motor sparing will also be quantified by assessing external rotation (suprascapular nerve). It will be assessed in degrees using a goniometer.

    Measured: 30 minutes post-SPSIP block

  3. Diaphragmatic Excursion

    The diaphramg excursion during normal breath will be evalauted by using an ultrasound machine (M-Mode) and measured in millimiters

    Measured: 30 minutes post-SPSIP block

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2026
  2. Study start14 Oct 2026
  3. Primary completionJan 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07874672
Sponsor's protocol ID
6603/U6/26
Status last verified
Oct 2026
First submitted
5 Oct 2026
Last updated
21 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Shoulder Arthroscopic Surgeries, run by ULSS6 - Ospedale di Piove di Sacco at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alessio Rotondi, Doctor (0039 3899224280, alessio.rotondi@aulss6.veneto.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sensory blockade at 30 minutes (time frame: 30 min after SPSIP block). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in